A possible hypothesis to justify this difference between the groups would be that the group with low PTH levels may have greater variation in calcium levels due to oral supplementation; therefore, transient hypercalcemia may increase the calcium–phosphorus product and promote vascular calcification (7). This evidence concerns the gene PTH and hypercalcemia disease.